Literature DB >> 11124955

SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting.

M S Rodriguez1, C Dargemont, R T Hay.   

Abstract

SUMO-1 is a small ubiquitin-related modifier that is covalently linked to many cellular protein targets. Proteins modified by SUMO-1 and the SUMO-1-activating and -conjugating enzymes are located predominantly in the nucleus. Here we define a transferable sequence containing the PsiKXE motif, where Psi represents a large hydrophobic amino acid, that confers the ability to be SUMO-1-modified on proteins to which it is linked. Whereas addition of short sequences from p53 and IkappaBalpha, containing the PsiKXE motif, to a carrier protein is sufficient for modification in vitro, modification in vivo requires the additional presence of a nuclear localization signal. Thus, protein substrates must be targeted to the nucleus to undergo SUMO-1 conjugation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11124955     DOI: 10.1074/jbc.M009476200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  324 in total

1.  SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein.

Authors:  C Endter; J Kzhyshkowska; R Stauber; T Dobner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

2.  PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.

Authors:  S Sachdev; L Bruhn; H Sieber; A Pichler; F Melchior; R Grosschedl
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

3.  Functional mimicry of the acetylated C-terminal tail of p53 by a SUMO-1 acetylated domain, SAD.

Authors:  Amrita Cheema; Chad D Knights; Mahadev Rao; Jason Catania; Ricardo Perez; Brigitte Simons; Sivanesan Dakshanamurthy; Vamsi K Kolukula; Maddalena Tilli; Priscilla A Furth; Christopher Albanese; Maria Laura Avantaggiati
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

4.  PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.

Authors:  Noora Kotaja; Ulla Karvonen; Olli A Jänne; Jorma J Palvimo
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

5.  Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex.

Authors:  Hong Zhang; Hisato Saitoh; Michael J Matunis
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

6.  SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression.

Authors:  Gergana Dobreva; Julia Dambacher; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2003-12-15       Impact factor: 11.361

7.  N4BP1 is a newly identified nucleolar protein that undergoes SUMO-regulated polyubiquitylation and proteasomal turnover at promyelocytic leukemia nuclear bodies.

Authors:  Prashant Sharma; Rodolfo Murillas; Huafeng Zhang; Michael R Kuehn
Journal:  J Cell Sci       Date:  2010-03-16       Impact factor: 5.285

Review 8.  Cardiac function and disease: emerging role of small ubiquitin-related modifier.

Authors:  Jun Wang
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

9.  SUMOylation pathway in Trypanosoma cruzi: functional characterization and proteomic analysis of target proteins.

Authors:  Julio C Bayona; Ernesto S Nakayasu; Marc Laverrière; Clemente Aguilar; Tiago J P Sobreira; Hyungwon Choi; Alexey I Nesvizhskii; Igor C Almeida; Juan J Cazzulo; Vanina E Alvarez
Journal:  Mol Cell Proteomics       Date:  2011-08-10       Impact factor: 5.911

10.  Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.

Authors:  Serge Grégoire; Xiang-Jiao Yang
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.